$RDNT Cashflow Statement | Understand Stock

$RDNT

$73.54 +$0.00 (0.0%) Close

$RDNT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Amortization of operating lease right-of-use assets
Non-cash lease expense
Equity in earnings of joint ventures, net of dividend
Amortization of deferred financing costs and loan discount
Loss on sale and disposal of equipment
Gain on re-measurement of pre-existing interest
Loss on impairment
Gain on contribution of imaging centers into joint venture
Lease abandonment charges
Amortization of cash flow hedge
Non-cash change in fair value of interest rate swaps
Stock-based compensation
Other non cash item in other expenses
Non cash item in other expenses
Change in fair value of contingent consideration
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:
Accounts receivable
Other current assets
Other assets
Deferred taxes
Operating lease liability
Deferred revenue
Accounts payable, accrued expenses and other

Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of imaging facilities and other acquisitions, net of cash acquired
Equity investments at fair value
Purchase of property and equipment
Purchase of intangible assets
Proceeds from sale of equipment
Proceeds from the sale of equity interests in a joint venture
Nulogix return of capital
Equity Contributions In Joint Ventures
Collection of notes receivable
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
Additional deferred finance costs on revolving loan amendment
Proceeds from paycheck protection program loans
Principal payments on notes and leases payable
Payments on term loan debt
Proceeds from issuance of debt, net of issuance costs
Sale of noncontrolling interests
Payments of contingent consideration and holdbacks
Distributions paid to noncontrolling interests
Contributions from noncontrolling partners
Proceeds from sale of economic interest in majority owned subsidiary
Proceeds from revolving credit facility
Payments on revolving credit facility
Proceeds from issuance of common stock
Proceeds from issuance of common stock upon exercise of options
Net cash provided by financing activities

EFFECT OF EXCHANGE RATE CHANGES ON CASH
NET INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of period
CASH AND CASH EQUIVALENTS, end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest
Cash paid during the period for income taxes

Comments